Inflammatory Bowel Diseases
3 competing products in clinical development for Inflammatory Bowel Diseases.
Pipeline by Phase
Pre-clinical1
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Infliximab + Infliximab + Infliximab | Celltrion | Approved | Recruiting | 85 |
| CT-P13 | Celltrion | Phase 3 | UNKNOWN | 77 |
| Subcutaneous infliximab CT-P13 Remsima®SC | Celltrion | Pre-clinical | UNKNOWN | 23 |